REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/01/2025
Back to search
Official data from USPTO
VITRIGEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VITRIGEL
ST13
US500000079274679Class
1, 5, 9, 10
Filing
79274679
Registration
6138690
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
09/02/2025
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
07/25/2019
Registration date
09/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
09/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
JP
Examiner
POLZER, NATALIE
Law office
L80
Current location
TMEG LAW OFFICE 108
Holders and representatives
Holders
N. O. (pessoa física)
Representatives
M. Scott Alprin Alprin Law Offices, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicals; chemicalschemical preparations for scientific laboratory use other than for medical or veterinary purposes; cell culture media for scientificlaboratory and research useother than for medical or veterinary purposes; microorganism cell culture media for laboratoryscientific and research useother than for medical or veterinary purposes; cell culture media for scientific or research purposes; cell culture media for laboratory use
Class 5
Pharmaceutical preparations for the treatment of wounds and cancer; chemical preparations for medical purposestreating ophthalmologicalotolaryngological and dermatological diseases or disorders; chemical preparations for pharmaceutical purposes for eye irritation testscorneal permeability testsskin sensitization testsvascular permeability testsliver metabolism and excretion tests and intestine absorption tests; collagen for medical purposes; surgical mesh comprised primarily of living tissue; patches comprising living tissues for skin regeneration; patches comprising living tissues for reinforcement of living tissues; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; transplantsimplants comprising living tissues; human allograft tissue; drug delivery agents in the form of sheetsthreads and hollow fibers that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; microcapsules for delivering drugs
Class 9
Laboratory apparatus and instruments for the exchange of substances and heat; measuring or testing machines and instrumentsscalesmeasuring glasswaretest tubes; incubators for laboratory use; cell culture apparatus for laboratory usecell culture dishes; cell culture apparatus for laboratory usetissue culture flasks; cell culture apparatus for research usebioreactor for cell culturing; furniture especially made and used for laboratorieschambers for cell culture for laboratory use; bioreactors for cell culture; cell chips being bio-chips for research or scientific purposes
Class 10
Medical apparatus and instruments for use in treating ophthalmologicalotolaryngological and dermatological diseases and conditions; artificial skin for medical purposes; artificial skin for surgical purposes; prosthetics or fillings materialsartificial materials for use in the replacement of bonesnot for dental use; surgical mesh comprised primarily of artificial materials; suture materials; thread for medical purposes; sutures; hollow fibers * fiber membranes * for medical use; apparatus for drug delivery systemsyringes sold filled with living cells; implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treatment of dermatological disease; prosthetic tissues for parietal use; prosthetic tissues for visceral use; prosthetic tissues for vascular use
Publications
History of USPTO decisions and trademark events.
29 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/07/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/05/2023
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
01/03/2023
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
11/29/2022
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/28/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/07/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/30/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/18/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
12/18/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2020
PUBO
PUBLISHED FOR OPPOSITION
06/16/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/14/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/13/2020
ALIE
ASSIGNED TO LIE
05/13/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2020
RFNT
REFUSAL PROCESSED BY IB
02/22/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/06/2020
RFRR
REFUSAL PROCESSED BY MPU
02/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/10/2020
CNRT
NON-FINAL ACTION WRITTEN
01/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/07/2020
DOCK
ASSIGNED TO EXAMINER
01/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/03/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/19/2019
Continuous trademark protection
Get notified about every new filing that threatens VITRIGEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.